Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry

Karolina Badora; Aleksandra Caban; Cécile Rémuzat; Claude Dussart; Mondher Toumi

Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry

Karolina Badora ¹ Aleksandra Caban ¹ Cécile Rémuzat ² Claude Dussart ^{3, 4} Mondher Toumi ⁵

1 Creativ-Ceutical Poland, Cracow, Poland.

2 Creativ-Ceutical, Paris , France

3 P2S - Parcours santé systémique

4 Faculté de Médecine Laennec, Université de Lyon, Lyon, France.

5 AMU MED - Aix-Marseille Université - Faculté de médecine

Abstract : In Poland, two proposed amendments to the reimbursement act are currently in preparation ; these are likely to substantially change the pricing and reimbursement landscape for both drugs and medical devices. Proposed changes include: alignment of medical device reimbursement with that of pharmaceuticals; relaxing the strict reimbursement criteria for ultra-orphan drugs; establishment of an additional funding category for vaccines; introduction of compassionate use, and a simplified reimbursement pathway for well-established off-label indications; appreciation of manufacturers' innovation and research and development efforts by creating a dedicated innovation budget; introduction of a mechanism preventing excessive parallel import; prolonged duration of reimbursement decisions and reimbursement lists; and increased flexibility in defining drug programmes. Both amendments are still at a draft stage and many aspects of the new regulations remain unclear. Nonetheless, the overall direction of some of the changes is already evident and warrants discussion due to their high expected impact on pharmaceutical and device manufacturers. Here we evaluate the main changes proposed to the reimbursement of drugs, vaccines, and medical devices, and examine the impact they are likely to have on market access and pharmaceutical industry in Poland. ARTICLE HISTORY

Keywords : medical devices drug policy Poland pharmaceuticals Pricing and reimbursement reimbursement policy

Document type :

Journal articles

Domain :

Humanities and Social Sciences / Economies and finances

Life Sciences [q-bio] / Santé publique et épidémiologie

Complete list of metadatas

Cited literature [32 references] Display Hide Download

https://hal-univ-lyon1.archives-ouvertes.fr/hal-01722743
Contributor : Catherine Billard <>
Submitted on : Monday, March 5, 2018 - 9:30:08 AM
Last modification on : Thursday, April 18, 2019 - 11:35:26 PM
Long-term archiving on : Wednesday, June 6, 2018 - 2:00:41 PM

Proposed changes to the reimbu...

Publisher files allowed on an open archive

Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry

File

Identifiers

Collections

Citation

Export

Metrics

137

235

Contact

Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry

File

Identifiers

Collections

Citation

Export

Share

Metrics

137

235

Contact